IPLEXMED develops the new generation of fast, portable, and connectable laboratory-grade genetic diagnostic devices for health support anytime, everywhere.

The future of diagnosis

Rapid diagnosis tests are part of the everyday life, but have inherent limitations such as a limited sensitivity.

We develop a platform based on graphene sensors to combine molecular diagnosis into rapid diagnosis tests will bring a new world of accurate diagnosis, connected to health providers and enabler of better health for all.

A wide range of applications

Applcaitions of DNA diagnosis are very wide. We focus on life-threatening pathogens. In our preliminary tests, our demonstrator funded by public funding demonstrated ability to detect the DNA of a single malaria parasite in a test performed in saliva.


The iplexmed electronic RDT is based on graphene field-effect transistors that show an extremely high sensitivity as compared to other existing sensing technologies.


Graphene is a bidimensional material that behaves as a zero-gap semiconductor, and can be used to form ambipolar transistors with a high charge carrier mobility. Behind the technicalities, the consequence is graphene is able to provide record levels of sensitivity and can detect extremely low levels of infectious agents


Most kinds of Rapid Diagnosis Tests (RDT) available today are based on proteins. Think of pregnancy tests. While these tests have served us well for the preivous decades, they have limitations: limited temperature stability, limited shelf life. They also have hard time discriminating closely related species of pathogens. It means one can obtain the level of detection only obtain in laboratory-grade detection using amplification techniques (PCR), while being portable.

Our sensors are based on DNA, the code of life. This makes them able to detect much more accurately infectious agents, and discriminate them very closely, and provide the best diagnosis possible.


Our high-technology portable sensor platform is able to embed several probes to detect simultaneously several agents, and discriminate them, providing wide panels of biomarkers for clinician to analyze.


The iplexmed team is all about creating solutions for today’s and tomorrow’s world where at-home diagnosis can help improve our living.

The team

Our team is composed of biologists, chemists, engineers.

The iplexmed team at INL (picture: INL)
Continue reading “Team”


They support iplexmed

They supported the idea at our host institutions before iplexmed was incorporated

The host institutions who funded the initial research